2017 San Antonio Breast Cancer Symposium - MyriadMyRisk

 


EVENTS


Join us Friday, December 8th from 8-11pm for Myriad Genetic Laboratories’

LOCATION: Landry’s Seafood House – 3rd floor
517 N. Presa St.
San Antonio, TX 78205

Food and drinks will be served!


SCIENTIFIC SESSIONS

We are excited to highlight below studies related to myRisk Hereditary Cancer and EndoPredict:


Poster Discussion PD1-08 // Wednesday, December 6th from 5:00pm-7:00pm

Development and Validation of a Combined Residual Risk Score to Predict Breast Cancer Risk in Unaffected Women Negative for Mutations on a Multi-Gene Hereditary Cancer Panel

Presented by: Elisha Hughes, PhD, Myriad Genetic Laboratories

 

Poster Discussion P3-08-01 // Thursday, December 7th from 5:00pm-7:00pm

Prognostic performance of EndoPredict in invasive lobular carcinoma

Presented by: Ivana Sestak, Ms, PhD, Queen Mary, University of London | QMUL · Wolfson Institute of Preventive Medicine

 

General Session 6 GS6-04 // Friday, December 8th at 4:00pm

The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrine therapy in HR+/HER2- breast cancer patients from ABCSG 34.

Presented by: Peter Dubsky, MD, Medical University of Vienna and Breast Center Klinik St. Anna, Lucerne


Myriad is a proud supporter of the following Research to Practice CME event:


Tuesday, December 5, 2017, 8:00 PM – 9:45 PM
at the San Antonio Marriott Rivercenter

Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer

Learn more and register online at:
http://www.researchtopractice.com/Meetings/PARP2017

Leave a Reply

Your email address will not be published. Required fields are marked *